Tidemark, LLC Immuneering Corp Transaction History
Tidemark, LLC
- $263 Million
- Q1 2025
A detailed history of Tidemark, LLC transactions in Immuneering Corp stock. As of the latest transaction made, Tidemark, LLC holds 44,400 shares of IMRX stock, worth $167,832. This represents 0.03% of its overall portfolio holdings.
Number of Shares
44,400
Previous 44,400
-0.0%
Holding current value
$167,832
Previous $97,000
30.93%
% of portfolio
0.03%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding IMRX
# of Institutions
36Shares Held
4.75MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.06MShares$4 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0808KShares$3.05 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD659KShares$2.49 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$2.02 Million0.0% of portfolio
-
Morgan Stanley New York, NY467KShares$1.77 Million0.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $99.8M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...